000-51598 | 77-0259335 | |
(Commission File Number) | (IRS Employer Identification No.) |
8 Crosby Drive, Bedford, Massachusetts | 01730 | |
(Address of Principal Executive Offices) | (Zip Code) |
Item 2.02 Results of Operations and Financial Condition. | ||||||||
Item 9.01 Financial Statements and Exhibits. | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
Ex-99.1 Press Release issued on October 22, 2008 |
Item 2.02 | Results of Operations and Financial Condition. |
Item 9.01 | Financial Statements and Exhibits. |
(d)
|
Exhibits: | |||
99.1 | Press Release issued by iRobot Corporation on October 22, 2008, furnished herewith. |
iRobot Corporation |
||||
October 22, 2008 | By: | /s/ Glen D. Weinstein | ||
Name: | Glen D. Weinstein | |||
Title: | General Counsel and Secretary | |||
Exhibit Number
|
Description | |
99.1
|
Press Release issued by iRobot Corporation on October 22, 2008, furnished herewith. |
Contacts: |
||
Elise Caffrey
|
Nancy Smith | |
Investor Relations
|
Media Relations | |
iRobot Corp.
|
iRobot Corp. | |
(781) 430-3003
|
(781) 430-3323 | |
ecaffrey@irobot.com
|
nsmith@irobot.com |
| In the third quarter, total home robot revenue increased 56 percent year-over-year. International home robot revenue was more than double the level of Q3 2007 and comprised approximately 26 percent of total home robot revenue in the quarter. |
| Government & Industrial division delivered a record 319 iRobot PackBots in the third quarter, driving a 31 percent revenue increase over Q3 2007. |
| In the third quarter, iRobot received $40 million in orders for robots and spare parts under its current $286 million xBot contract with the U.S. Army Program Executive Office for Simulation, Training, and Instrumentation (PEO STRI). |
| iRobot announced its acquisition of Nekton Research, LLC, an unmanned underwater robot and technology company based in Raleigh-Durham, North Carolina. |
| On October 6, the companys portfolio of auction rate security investments was redeemed at par for $16.2 million. |
For the three months ended | For the nine months ended | |||||||||||||||
September 27, | September 29, | September 27, | September 29, | |||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
Revenue |
||||||||||||||||
Product revenue |
$ | 87,224 | $ | 58,667 | $ | 198,475 | $ | 134,149 | ||||||||
Contract revenue |
5,191 | 5,173 | 18,444 | 16,192 | ||||||||||||
Total |
92,415 | 63,840 | 216,919 | 150,341 | ||||||||||||
Cost of Revenue |
||||||||||||||||
Product revenue |
58,371 | 39,186 | 138,948 | 89,910 | ||||||||||||
Contract revenue |
5,114 | 4,542 | 17,213 | 13,978 | ||||||||||||
Total |
63,485 | 43,728 | 156,161 | 103,888 | ||||||||||||
Gross Profit |
28,930 | 20,112 | 60,758 | 46,453 | ||||||||||||
Operating Expense |
||||||||||||||||
Research & development |
4,940 | 4,739 | 13,631 | 13,074 | ||||||||||||
Selling & marketing |
10,522 | 11,115 | 35,451 | 30,108 | ||||||||||||
General & administrative |
7,578 | 6,459 | 21,696 | 17,538 | ||||||||||||
Total |
23,040 | 22,313 | 70,778 | 60,720 | ||||||||||||
Operating (loss) income |
5,890 | (2,201 | ) | (10,020 | ) | (14,267 | ) | |||||||||
Other income, net |
180 | 845 | 917 | 2,663 | ||||||||||||
Pre-tax (loss) income |
6,070 | (1,356 | ) | (9,103 | ) | (11,604 | ) | |||||||||
Income tax expense (benefit) |
2,218 | 22 | (4,437 | ) | 51 | |||||||||||
Net (loss) income |
$ | 3,852 | $ | (1,378 | ) | $ | (4,666 | ) | $ | (11,655 | ) | |||||
Net (loss) income per common share: |
||||||||||||||||
Basic |
$ | 0.16 | $ | (0.06 | ) | $ | (0.19 | ) | $ | (0.48 | ) | |||||
Diluted |
$ | 0.15 | $ | (0.06 | ) | $ | (0.19 | ) | $ | (0.48 | ) | |||||
Shares used in Per Common Share Calculations: |
||||||||||||||||
Basic |
24,712 | 24,337 | 24,614 | 24,156 | ||||||||||||
Diluted |
25,536 | 24,337 | 24,614 | 24,156 | ||||||||||||
Stock-based compensation included in above figures: |
||||||||||||||||
Cost of product revenue |
$ | 184 | $ | 162 | $ | 554 | $ | 521 | ||||||||
Cost of contract revenue |
127 | 81 | 300 | 292 | ||||||||||||
Research & development |
131 | 134 | 226 | 252 | ||||||||||||
Selling & marketing |
305 | 226 | 733 | 833 | ||||||||||||
General & administrative |
1,090 | 627 | 2,495 | 1,517 | ||||||||||||
Total |
$ | 1,837 | $ | 1,230 | $ | 4,308 | $ | 3,415 | ||||||||
September 27, | December 29, | |||||||
2008 | 2007 | |||||||
(unaudited) | (audited) | |||||||
Assets |
||||||||
Cash and equivalents |
$ | 10,515 | $ | 26,735 | ||||
Short term investments |
16,197 | 16,550 | ||||||
Accounts receivable, net |
46,321 | 47,681 | ||||||
Unbilled revenues |
2,272 | 2,244 | ||||||
Inventory, net |
42,596 | 45,222 | ||||||
Deferred tax assets |
5,905 | 5,905 | ||||||
Other current assets |
9,228 | 2,268 | ||||||
Total current assets |
133,034 | 146,605 | ||||||
Property, plant and equipment, net |
24,139 | 15,694 | ||||||
Deferred tax assets |
4,293 | 4,293 | ||||||
Other assets |
12,371 | 2,500 | ||||||
Total assets |
$ | 173,837 | $ | 169,092 | ||||
Liabilities and stockholders equity |
||||||||
Accounts payable |
$ | 31,870 | $ | 44,697 | ||||
Accrued expenses |
9,392 | 7,987 | ||||||
Accrued compensation |
8,262 | 4,603 | ||||||
Deferred revenue |
2,733 | 1,578 | ||||||
Total current liabilities |
52,257 | 58,865 | ||||||
Long term liabilities |
10,052 | | ||||||
Stockholders equity |
111,528 | 110,227 | ||||||
Total liabilities and stockholders equity |
$ | 173,837 | $ | 169,092 | ||||
For the three months ended | For the nine months ended | |||||||||||||||||||||||||||
September 27, | September 29, | September 27, | September 29, | |||||||||||||||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||||||||||||||
(unaudited) | (unaudited) | |||||||||||||||||||||||||||
Cash flows from operating activities: |
||||||||||||||||||||||||||||
Net (loss) income |
$ | 3,852 | $ | (1,378 | ) | $ | (4,666 | ) | $ | (11,655 | ) | |||||||||||||||||
Adjustments to reconcile net (loss) income to net cash used in
operating activities: |
||||||||||||||||||||||||||||
Depreciation and amortization |
1,844 | 1,530 | 5,135 | 3,989 | ||||||||||||||||||||||||
Loss on disposal of fixed assets |
12 | 13 | 80 | 48 | ||||||||||||||||||||||||
Stock-based compensation |
1,837 | 1,230 | 4,308 | 3,415 | ||||||||||||||||||||||||
In-process research and development relating to acquisition of
Nekton Research LLC |
200 | | 200 | | ||||||||||||||||||||||||
Non-cash director deferred compensation |
24 | 28 | 71 | 83 | ||||||||||||||||||||||||
Changes in working capital (use) source |
||||||||||||||||||||||||||||
Accounts receivable |
(21,598 | ) | (17,478 | ) | 1,830 | (6,647 | ) | |||||||||||||||||||||
Unbilled revenue |
(82 | ) | (1,268 | ) | (28 | ) | (796 | ) | ||||||||||||||||||||
Inventory |
692 | (21,703 | ) | 2,626 | (22,821 | ) | ||||||||||||||||||||||
Other assets |
1,186 | (59 | ) | (6,930 | ) | 824 | ||||||||||||||||||||||
Accounts payable |
7,192 | 18,842 | (13,540 | ) | 18,263 | |||||||||||||||||||||||
Accrued expenses |
1,226 | 102 | 1,405 | (1,919 | ) | |||||||||||||||||||||||
Accrued compensation |
1,481 | 2,075 | 3,503 | 2,361 | ||||||||||||||||||||||||
Deferred revenue |
1,755 | (774 | ) | 1,127 | 683 | |||||||||||||||||||||||
Change in long term liabilities |
(107 | ) | | 4,552 | | |||||||||||||||||||||||
Net cash used in operating activities |
(486 | ) | (18,840 | ) | (327 | ) | (14,172 | ) | ||||||||||||||||||||
Cash flows from investing activities: |
||||||||||||||||||||||||||||
Purchase of property and equipment |
(1,312 | ) | (2,535 | ) | (13,589 | ) | (6,456 | ) | ||||||||||||||||||||
Purchase of Nekton Research LLC, net of cash received |
(9,745 | ) | | (9,745 | ) | | ||||||||||||||||||||||
Purchases of investments |
| (22,750 | ) | (29,997 | ) | (44,750 | ) | |||||||||||||||||||||
Sales of investments |
1,300 | 56,450 | 30,350 | 83,250 | ||||||||||||||||||||||||
Net cash provided by (used in) investing activities |
(9,757 | ) | 31,165 | (22,981 | ) | 32,044 | ||||||||||||||||||||||
Cash flows from financing activities: |
||||||||||||||||||||||||||||
Borrowings under revolving line of credit |
5,500 | | 5,500 | | ||||||||||||||||||||||||
Income tax withholding payment associated with stock option exercise |
| | | (1,588 | ) | |||||||||||||||||||||||
Proceeds from stock option exercises |
176 | 614 | 908 | 1,333 | ||||||||||||||||||||||||
Tax benefit of disqualifying dispositions |
322 | | 680 | | ||||||||||||||||||||||||
Net cash provided by (used in) financing activities |
5,998 | 614 | 7,088 | (255 | ) | |||||||||||||||||||||||
Net increase (decrease) in cash and cash equivalents |
(4,245 | ) | 12,939 | (16,220 | ) | 17,617 | ||||||||||||||||||||||
Cash and cash equivalents, at beginning of period |
14,760 | 10,261 | 26,735 | 5,583 | ||||||||||||||||||||||||
Cash and cash equivalents, at end of period |
$ | 10,515 | $ | 23,200 | $ | 10,515 | $ | 23,200 | ||||||||||||||||||||
For the three months ended | For the nine months ended | |||||||||||||||
September 27, | September 29, | September 27, | September 29, | |||||||||||||
2008 | 2007 | 2008 | 2007 | |||||||||||||
Revenue by business unit (in thousands): |
||||||||||||||||
Home Robots |
||||||||||||||||
Product |
$ | 53,626 | $ | 34,294 | $ | 125,424 | $ | 70,932 | ||||||||
Contract |
| 25 | 55 | 25 | ||||||||||||
Government & Industrial |
||||||||||||||||
Product |
33,598 | 24,373 | 73,051 | 63,217 | ||||||||||||
Contract |
5,191 | 5,148 | 18,389 | 16,167 | ||||||||||||
$ | 92,415 | $ | 63,840 | $ | 216,919 | $ | 150,341 | |||||||||
Direct Revenue Home Robots (in thousands) |
$ | 6,777 | $ | 7,732 | $ | 22,514 | $ | 20,456 | ||||||||
Product Lifecycle Revenue Government & Industrial
(in thousands) |
$ | 5,977 | $ | 9,631 | $ | 11,351 | $ | 14,488 | ||||||||
International Revenue (in thousands): |
||||||||||||||||
Home Robots |
$ | 14,203 | $ | 6,095 | $ | 42,784 | $ | 11,397 | ||||||||
Government & Industrial |
$ | 4,360 | $ | 2,997 | $ | 5,570 | $ | 7,866 | ||||||||
Average selling prices for robot units: |
||||||||||||||||
Home Robots |
$ | 138 | $ | 137 | $ | 150 | $ | 138 | ||||||||
Government & Industrial (in thousands) |
$ | 87 | $ | 129 | $ | 96 | $ | 134 | ||||||||
Gross Profit by business unit (in thousands): |
||||||||||||||||
Home Robots |
$ | 14,867 | $ | 8,700 | $ | 33,695 | $ | 19,969 | ||||||||
Government & Industrial |
14,063 | 11,412 | 27,063 | 26,484 | ||||||||||||
$ | 28,930 | $ | 20,112 | $ | 60,758 | $ | 46,453 | |||||||||
Units shipped by business unit: |
||||||||||||||||
Home Robots (in thousands) |
355 | 229 | 761 | 456 | ||||||||||||
Government & Industrial |
319 | 114 | 645 | 363 | ||||||||||||
Government & Industrial Funded Backlog (in thousands) |
$ | 36,621 | $ | 35,770 | $ | 36,621 | $ | 35,770 | ||||||||
Days sales outstanding |
48 | 54 | 48 | 54 | ||||||||||||
Inventory turnover |
5.5 | 3.6 | 5.5 | 3.6 | ||||||||||||
Net cash used in operating activities (in thousands) |
$ | (486 | ) | $ | (18,840 | ) | $ | (327 | ) | $ | (14,172 | ) | ||||
Headcount |
505 | 418 | 505 | 418 |